Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Alexza appoints new senior VP and COO

This article was originally published in Scrip

Executive Summary

Alexza Pharmaceuticals – which develops treatments for central nervous system conditions including acute repetitive seizures and insomnia – has appointed Peter Schineller senior vice-president and chief commercial officer. Prior to joining Mountain View, California based-Alexza, Mr Schineller served as senior vice-president and general manager at Ventana Medical Systems, a diagnostic company owned by Roche. He will oversee Alexza's global commercialization efforts and strategies for its first approved product Adasuve (Staccatoloxapine) and will report to president and CEO, Thomas King.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts